Holen Sie sich die Stockscreener-App
8.50
3.03%
0.25
Vorhandelsmarkt:
8.50
Schlusskurs vom Vortag:
$8.25
Offen:
$8.18
24-Stunden-Volumen:
854.33K
Relative Volume:
1.30
Marktkapitalisierung:
$459.78M
Einnahmen:
$2.81M
Nettoeinkommen (Verlust:
$-97.34M
KGV:
-5.3797
EPS:
-1.58
Netto-Cashflow:
$-91.47M
1W Leistung:
+12.73%
1M Leistung:
+32.61%
6M Leistung:
+173.31%
1J Leistung:
+144.96%
1-Tages-Spanne:
$7.94
$8.52
1-Wochen-Bereich:
$7.21
$8.52
52-Wochen-Spanne:
$2.315
$8.52
Fulcrum Therapeutics Inc Stock (FULC) Company Profile
Firmenname
Fulcrum Therapeutics Inc
Sektor
Branche
Telefon
617-651-8851
Adresse
26 LANDSDOWNE STREET, CAMBRIDGE, MA
Vergleichen Sie FULC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FULC
Fulcrum Therapeutics Inc
|
8.50 | 446.26M | 2.81M | -97.34M | -91.47M | -1.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
381.87 | 96.56B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.58 | 60.08B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.51 | 61.15B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
711.09 | 44.66B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
328.71 | 36.23B | 3.81B | -644.79M | -669.77M | -6.24 |
Fulcrum Therapeutics Inc Stock (FULC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-29 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2025-05-23 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-05-15 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2024-09-13 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-09-12 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-09-12 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-09-12 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-09-12 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-09-12 | Herabstufung | Stifel | Buy → Hold |
| 2024-09-09 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-05-20 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-03-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-09-25 | Eingeleitet | Goldman | Neutral |
| 2023-08-23 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2023-08-22 | Hochstufung | Stifel | Hold → Buy |
| 2023-05-04 | Herabstufung | Goldman | Buy → Neutral |
| 2023-03-10 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2023-03-10 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2023-03-09 | Herabstufung | Stifel | Buy → Hold |
| 2023-02-28 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-02-24 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-11-15 | Eingeleitet | Goldman | Buy |
| 2022-03-08 | Eingeleitet | Oppenheimer | Outperform |
| 2022-03-03 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2021-08-11 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-03-22 | Eingeleitet | Credit Suisse | Outperform |
| 2021-03-02 | Eingeleitet | Stifel | Buy |
| 2020-10-16 | Eingeleitet | Piper Sandler | Overweight |
| 2020-08-12 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2020-08-12 | Bestätigt | H.C. Wainwright | Buy |
| 2020-08-12 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-06-19 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2020-06-17 | Eingeleitet | BTIG Research | Buy |
| 2019-10-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-08-12 | Eingeleitet | BofA/Merrill | Buy |
Alle ansehen
Fulcrum Therapeutics Inc Aktie (FULC) Neueste Nachrichten
Can Fulcrum Therapeutics Inc. stock sustain market leadership2025 Bull vs Bear & High Return Trade Opportunity Guides - newser.com
Pociredir Trial And DBA IND Filing Put Fulcrum Therapeutics On Watchlist - RTTNews
Is Fulcrum Therapeutics Inc. stock trading near support levelsQuarterly Earnings Report & Reliable Price Breakout Signals - newser.com
Will Fulcrum Therapeutics Inc. stock outperform value stocksJuly 2025 Outlook & Capital Efficiency Focused Strategies - The British Mountaineering Council
Pattern recognition hints at Fulcrum Therapeutics Inc. upsidePrice Action & Risk Managed Investment Signals - newser.com
What earnings revisions data tells us about Fulcrum Therapeutics Inc.2025 Price Action Summary & Long-Term Growth Plans - newser.com
Strs Ohio Makes New Investment in Fulcrum Therapeutics, Inc. $FULC - MarketBeat
Fulcrum Therapeutics Inc. recovery potential after sell offIPO Watch & Entry Point Strategy Guides - newser.com
What does recent volatility data suggest for Fulcrum Therapeutics Inc.Wall Street Watch & Risk Adjusted Buy/Sell Alerts - newser.com
Volume spikes in Fulcrum Therapeutics Inc. stock – what they meanJuly 2025 Outlook & Short-Term High Return Ideas - newser.com
Goldman Sachs Group Inc. Reduces Holdings in Fulcrum Therapeutics, Inc. $FULC - Defense World
Goldman Sachs Group Inc. Sells 139,658 Shares of Fulcrum Therapeutics, Inc. $FULC - MarketBeat
Fulcrum Therapeutics, Inc. $FULC Shares Acquired by Acadian Asset Management LLC - MarketBeat
Whats next for Fulcrum Therapeutics Inc stockJuly 2025 Macro Moves & Real-Time Chart Pattern Alerts - خودرو بانک
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Tech Rally: Is FSHP stock forming a triangle patternTrade Performance Summary & Weekly Hot Stock Watchlists - khodrobank.com
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Short Interest Down 36.1% in August - MarketBeat
Can Fulcrum Therapeutics Inc deliver alpha2025 Price Momentum & Daily Chart Pattern Signal Reports - خودرو بانک
Price Action: Can Strats Trust Wal Mart Stores Inc. Preferred Security sustain its profitabilityAnalyst Upgrade & Daily Oversold Bounce Ideas - khodrobank.com
Technical analysis overview for Fulcrum Therapeutics Inc. stockJuly 2025 Analyst Calls & Precise Buy Zone Tips - newser.com
Smart Money: Is Fulcrum Therapeutics Inc stock undervalued right nowJuly 2025 Highlights & Short-Term Swing Trade Alerts - خودرو بانک
Market Outlook: Whats the fair value of Fulcrum Therapeutics Inc stockNew Guidance & Technical Pattern Based Buy Signals - خودرو بانک
EPS Watch: Is Fulcrum Therapeutics Inc forming higher highs and higher lowsTrade Analysis Report & Accurate Buy Signal Notifications - khodrobank.com
Published on: 2025-09-19 12:52:11 - khodrobank.com
CEO Moves: Is Fulcrum Therapeutics Inc. forming higher highs and higher lows2025 EndofYear Setup & Real-Time Volume Analysis Alerts - khodrobank.com
Fulcrum Therapeutics jumps amid takeover speculation - MSN
H.C. Wainwright Maintains Fulcrum Therapeutics(FULC.US) With Buy Rating, Maintains Target Price $12 - 富途牛牛
Acadian Asset Management LLC Increases Stock Position in Fulcrum Therapeutics, Inc. $FULC - Defense World
Jacobs Levy Equity Management Inc. Purchases New Holdings in Fulcrum Therapeutics, Inc. $FULC - MarketBeat
Here's Why We're Not Too Worried About Fulcrum Therapeutics' (NASDAQ:FULC) Cash Burn Situation - Yahoo Finance
Aug PostEarnings: Will Fulcrum Therapeutics Inc outperform tech stocksTrade Analysis Summary & Community Verified Trade Signals - خودرو بانک
Risk Check: Can Fulcrum Therapeutics Inc disrupt its industry2025 Breakouts & Breakdowns & Daily Profit Focused Stock Screening - خودرو بانک
Fulcrum reduces its workforce - MSN
Published on: 2025-09-16 21:20:39 - خودرو بانک
Trading Action: Will Immunocore Holdings plc Depositary Receipt outperform tech stocksTrade Analysis Summary & Free Expert Verified Stock Movement Alerts - خودرو بانک
Guidance Update: Can Fulcrum Therapeutics Inc keep up with sector leadersJuly 2025 Review & Safe Swing Trade Setup Alerts - خودرو بانک
Published on: 2025-09-16 05:16:04 - خودرو بانک
Market Overview: Is IF Bancorp Inc in a long term uptrendStock Surge & High Yield Equity Trading Tips - خودرو بانک
Aug Update: Is Fulcrum Therapeutics Inc in a bullish channelWeekly Investment Recap & Free Technical Confirmation Trade Alerts - khodrobank.com
Market Catalysts: Is Fulcrum Therapeutics Inc benefiting from innovation trendsJuly 2025 Patterns & Expert Approved Momentum Ideas - خودرو بانک
Applying chart zones and confluence areas to Fulcrum Therapeutics Inc.Portfolio Update Summary & Stepwise Entry and Exit Trade Signals - newser.com
BofA Securities Maintains Fulcrum Therapeutics(FULC.US) With Sell Rating, Maintains Target Price $6 - 富途牛牛
Fulcrum Therapeutics, Inc. $FULC Shares Bought by Exome Asset Management LLC - MarketBeat
Published on: 2025-09-15 03:06:05 - newser.com
Finanzdaten der Fulcrum Therapeutics Inc-Aktie (FULC)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):